| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 50 | 2024 | 154 | 12.370 |
Why?
|
| Gynecologic Surgical Procedures | 46 | 2024 | 148 | 11.330 |
Why?
|
| Urinary Incontinence, Stress | 59 | 2024 | 196 | 8.150 |
Why?
|
| Urinary Incontinence | 44 | 2024 | 213 | 8.130 |
Why?
|
| Gynecology | 20 | 2023 | 129 | 5.490 |
Why?
|
| Suburethral Slings | 25 | 2024 | 75 | 5.330 |
Why?
|
| Obstetrics | 15 | 2022 | 123 | 5.000 |
Why?
|
| Uterine Prolapse | 37 | 2024 | 80 | 4.610 |
Why?
|
| Hysterectomy | 27 | 2024 | 151 | 4.520 |
Why?
|
| Urologic Surgical Procedures | 22 | 2021 | 147 | 4.300 |
Why?
|
| Pelvic Floor | 25 | 2024 | 85 | 4.270 |
Why?
|
| Urethra | 22 | 2021 | 115 | 4.210 |
Why?
|
| Pelvic Floor Disorders | 13 | 2024 | 55 | 3.730 |
Why?
|
| Urinary Bladder | 29 | 2023 | 246 | 3.580 |
Why?
|
| Vagina | 23 | 2024 | 173 | 3.210 |
Why?
|
| Female | 252 | 2024 | 46011 | 3.190 |
Why?
|
| Laparoscopy | 21 | 2024 | 771 | 2.990 |
Why?
|
| Urinary Bladder, Overactive | 15 | 2024 | 90 | 2.680 |
Why?
|
| Patient Satisfaction | 18 | 2023 | 461 | 2.640 |
Why?
|
| Anal Canal | 12 | 2021 | 88 | 2.590 |
Why?
|
| Urinary Tract | 5 | 2023 | 35 | 2.520 |
Why?
|
| Urodynamics | 28 | 2022 | 122 | 2.480 |
Why?
|
| Humans | 261 | 2024 | 89063 | 2.270 |
Why?
|
| Middle Aged | 153 | 2024 | 25863 | 2.250 |
Why?
|
| Postoperative Complications | 40 | 2024 | 2275 | 2.130 |
Why?
|
| Urinary Incontinence, Urge | 16 | 2024 | 45 | 2.030 |
Why?
|
| Lacerations | 6 | 2021 | 28 | 2.010 |
Why?
|
| Lower Urinary Tract Symptoms | 13 | 2024 | 67 | 1.970 |
Why?
|
| Fecal Incontinence | 17 | 2021 | 57 | 1.970 |
Why?
|
| Surgical Mesh | 18 | 2024 | 122 | 1.920 |
Why?
|
| Robotic Surgical Procedures | 9 | 2024 | 304 | 1.890 |
Why?
|
| Adult | 122 | 2024 | 26507 | 1.810 |
Why?
|
| Aged | 108 | 2024 | 19077 | 1.760 |
Why?
|
| Surveys and Questionnaires | 50 | 2022 | 2612 | 1.720 |
Why?
|
| Internship and Residency | 13 | 2023 | 1041 | 1.650 |
Why?
|
| Quality of Life | 36 | 2023 | 1662 | 1.500 |
Why?
|
| Reoperation | 6 | 2022 | 598 | 1.460 |
Why?
|
| Ureter | 3 | 2020 | 93 | 1.440 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2024 | 251 | 1.380 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2024 | 599 | 1.340 |
Why?
|
| Postoperative Care | 3 | 2021 | 229 | 1.320 |
Why?
|
| Surgeons | 3 | 2022 | 247 | 1.310 |
Why?
|
| Prospective Studies | 36 | 2023 | 4273 | 1.290 |
Why?
|
| Treatment Outcome | 50 | 2024 | 8203 | 1.270 |
Why?
|
| Obstetric Labor Complications | 4 | 2021 | 34 | 1.270 |
Why?
|
| Leadership | 2 | 2022 | 138 | 1.260 |
Why?
|
| Dyspareunia | 3 | 2023 | 19 | 1.170 |
Why?
|
| Robotics | 4 | 2014 | 269 | 1.170 |
Why?
|
| Educational Measurement | 3 | 2018 | 231 | 1.150 |
Why?
|
| Retrospective Studies | 44 | 2024 | 9003 | 1.140 |
Why?
|
| Clinical Competence | 6 | 2022 | 780 | 1.130 |
Why?
|
| Sexism | 4 | 2023 | 53 | 1.120 |
Why?
|
| Microbiota | 3 | 2022 | 398 | 1.090 |
Why?
|
| Cystoscopy | 3 | 2020 | 39 | 1.030 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2021 | 50 | 1.010 |
Why?
|
| Cross-Sectional Studies | 19 | 2024 | 1706 | 1.000 |
Why?
|
| Hysteroscopy | 2 | 2015 | 6 | 0.990 |
Why?
|
| Defecation | 5 | 2013 | 23 | 0.980 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 37 | 0.980 |
Why?
|
| Extraction, Obstetrical | 2 | 2021 | 7 | 0.970 |
Why?
|
| Sensory Thresholds | 4 | 2012 | 55 | 0.940 |
Why?
|
| Neurons, Afferent | 4 | 2008 | 79 | 0.940 |
Why?
|
| Quality Improvement | 5 | 2022 | 447 | 0.940 |
Why?
|
| Family Planning Services | 3 | 2019 | 36 | 0.890 |
Why?
|
| Obstetric Surgical Procedures | 2 | 2017 | 10 | 0.890 |
Why?
|
| Hospitals, Religious | 3 | 2019 | 29 | 0.890 |
Why?
|
| Curriculum | 6 | 2020 | 567 | 0.860 |
Why?
|
| Abdomen | 4 | 2020 | 122 | 0.860 |
Why?
|
| Uterine Neoplasms | 2 | 2021 | 245 | 0.860 |
Why?
|
| Intraoperative Complications | 6 | 2020 | 188 | 0.840 |
Why?
|
| Referral and Consultation | 4 | 2021 | 341 | 0.830 |
Why?
|
| Urination Disorders | 8 | 2022 | 50 | 0.830 |
Why?
|
| Clinical Decision-Making | 2 | 2024 | 280 | 0.830 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 46 | 0.820 |
Why?
|
| Pelvic Pain | 4 | 2024 | 84 | 0.820 |
Why?
|
| Behavior Therapy | 6 | 2013 | 84 | 0.820 |
Why?
|
| Pregnancy | 21 | 2024 | 3009 | 0.810 |
Why?
|
| Supine Position | 2 | 2020 | 30 | 0.810 |
Why?
|
| Personnel Selection | 2 | 2023 | 60 | 0.800 |
Why?
|
| Pressure | 5 | 2020 | 165 | 0.800 |
Why?
|
| Correspondence as Topic | 1 | 2021 | 4 | 0.790 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 121 | 0.780 |
Why?
|
| Early Detection of Cancer | 3 | 2014 | 415 | 0.770 |
Why?
|
| Neuromuscular Junction | 3 | 2015 | 81 | 0.760 |
Why?
|
| Convalescence | 1 | 2021 | 12 | 0.760 |
Why?
|
| Uterus | 4 | 2012 | 222 | 0.760 |
Why?
|
| United States | 23 | 2024 | 6955 | 0.760 |
Why?
|
| Neuromuscular Agents | 1 | 2021 | 26 | 0.740 |
Why?
|
| Pessaries | 6 | 2015 | 9 | 0.730 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 295 | 0.730 |
Why?
|
| Watchful Waiting | 1 | 2021 | 63 | 0.720 |
Why?
|
| Aged, 80 and over | 40 | 2022 | 6777 | 0.710 |
Why?
|
| Hematuria | 2 | 2017 | 50 | 0.700 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 64 | 0.700 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 105 | 0.700 |
Why?
|
| Patient Participation | 2 | 2021 | 224 | 0.700 |
Why?
|
| Cesarean Section | 4 | 2020 | 140 | 0.700 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2019 | 5 | 0.690 |
Why?
|
| Racism | 1 | 2021 | 89 | 0.680 |
Why?
|
| Sex Characteristics | 1 | 2022 | 324 | 0.680 |
Why?
|
| Patient Positioning | 1 | 2020 | 65 | 0.680 |
Why?
|
| Cystitis, Interstitial | 3 | 2017 | 53 | 0.670 |
Why?
|
| Severity of Illness Index | 25 | 2019 | 1837 | 0.670 |
Why?
|
| Urologic Diseases | 1 | 2019 | 44 | 0.660 |
Why?
|
| Electromyography | 9 | 2021 | 193 | 0.660 |
Why?
|
| Patient Compliance | 4 | 2014 | 230 | 0.660 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 205 | 0.660 |
Why?
|
| Religion and Medicine | 2 | 2011 | 124 | 0.660 |
Why?
|
| Self Care | 2 | 2019 | 164 | 0.650 |
Why?
|
| Phenylpropanolamine | 5 | 2011 | 15 | 0.640 |
Why?
|
| Muscarinic Antagonists | 6 | 2011 | 58 | 0.640 |
Why?
|
| Cresols | 5 | 2011 | 17 | 0.640 |
Why?
|
| Hysterectomy, Vaginal | 6 | 2022 | 15 | 0.640 |
Why?
|
| Benzhydryl Compounds | 5 | 2011 | 44 | 0.630 |
Why?
|
| Postoperative Period | 8 | 2024 | 301 | 0.620 |
Why?
|
| Staff Development | 1 | 2018 | 26 | 0.610 |
Why?
|
| Workplace | 1 | 2018 | 29 | 0.610 |
Why?
|
| Postpartum Period | 9 | 2023 | 144 | 0.610 |
Why?
|
| Goals | 7 | 2021 | 67 | 0.600 |
Why?
|
| Exercise | 1 | 2021 | 322 | 0.590 |
Why?
|
| Feedback | 1 | 2018 | 134 | 0.580 |
Why?
|
| Lactobacillus acidophilus | 1 | 2017 | 7 | 0.580 |
Why?
|
| Parturition | 3 | 2023 | 21 | 0.580 |
Why?
|
| Cohort Studies | 14 | 2024 | 2863 | 0.580 |
Why?
|
| Chemokine CCL22 | 1 | 2017 | 8 | 0.580 |
Why?
|
| Leiomyoma | 1 | 2021 | 200 | 0.570 |
Why?
|
| Directive Counseling | 1 | 2017 | 35 | 0.570 |
Why?
|
| Interleukin-4 | 1 | 2017 | 130 | 0.550 |
Why?
|
| Patient Handoff | 1 | 2018 | 95 | 0.550 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 105 | 0.550 |
Why?
|
| Reproducibility of Results | 17 | 2022 | 2752 | 0.540 |
Why?
|
| Faculty, Medical | 1 | 2018 | 185 | 0.530 |
Why?
|
| Delivery, Obstetric | 9 | 2021 | 118 | 0.530 |
Why?
|
| Operative Time | 5 | 2024 | 142 | 0.530 |
Why?
|
| Young Adult | 20 | 2022 | 6288 | 0.510 |
Why?
|
| Rectocele | 2 | 2014 | 7 | 0.500 |
Why?
|
| Time-to-Treatment | 3 | 2021 | 112 | 0.500 |
Why?
|
| Pain Measurement | 7 | 2021 | 328 | 0.500 |
Why?
|
| Man-Machine Systems | 1 | 2014 | 10 | 0.490 |
Why?
|
| Musculoskeletal Pain | 1 | 2014 | 10 | 0.490 |
Why?
|
| Time Factors | 20 | 2024 | 5320 | 0.490 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2014 | 32 | 0.470 |
Why?
|
| Electronic Health Records | 3 | 2023 | 341 | 0.470 |
Why?
|
| Occupational Diseases | 1 | 2014 | 56 | 0.470 |
Why?
|
| Urogenital Surgical Procedures | 3 | 2007 | 10 | 0.460 |
Why?
|
| Education, Medical, Graduate | 4 | 2020 | 390 | 0.460 |
Why?
|
| Logistic Models | 11 | 2021 | 1212 | 0.460 |
Why?
|
| Education, Medical | 2 | 2014 | 243 | 0.450 |
Why?
|
| Vaginal Birth after Cesarean | 3 | 2021 | 7 | 0.440 |
Why?
|
| Peripartum Period | 1 | 2013 | 30 | 0.440 |
Why?
|
| Pain | 8 | 2023 | 400 | 0.430 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 3657 | 0.430 |
Why?
|
| Medical Records | 4 | 2008 | 120 | 0.430 |
Why?
|
| Preoperative Period | 4 | 2020 | 94 | 0.420 |
Why?
|
| Male | 20 | 2024 | 42251 | 0.420 |
Why?
|
| Nocturia | 4 | 2024 | 19 | 0.420 |
Why?
|
| Suture Techniques | 5 | 2020 | 140 | 0.420 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 19 | 0.410 |
Why?
|
| Double-Blind Method | 4 | 2021 | 1714 | 0.410 |
Why?
|
| Constipation | 4 | 2018 | 63 | 0.410 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 251 | 0.410 |
Why?
|
| Guideline Adherence | 2 | 2014 | 229 | 0.410 |
Why?
|
| Mental Recall | 3 | 2013 | 157 | 0.400 |
Why?
|
| Public Health | 2 | 2023 | 137 | 0.400 |
Why?
|
| Risk Factors | 19 | 2024 | 5466 | 0.390 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 250 | 0.390 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 228 | 0.390 |
Why?
|
| Operating Rooms | 2 | 2018 | 129 | 0.390 |
Why?
|
| Biomedical Research | 3 | 2015 | 398 | 0.380 |
Why?
|
| Muscles | 1 | 2011 | 193 | 0.380 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2011 | 21 | 0.380 |
Why?
|
| Needs Assessment | 3 | 2020 | 157 | 0.380 |
Why?
|
| Sexual Behavior | 4 | 2018 | 309 | 0.370 |
Why?
|
| Electrophysiology | 2 | 2008 | 403 | 0.370 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 31 | 0.370 |
Why?
|
| Case-Control Studies | 8 | 2024 | 1855 | 0.360 |
Why?
|
| Urination | 1 | 2010 | 37 | 0.350 |
Why?
|
| Pilot Projects | 7 | 2021 | 865 | 0.350 |
Why?
|
| Personality | 1 | 2011 | 134 | 0.350 |
Why?
|
| Pelvis | 5 | 2021 | 96 | 0.350 |
Why?
|
| Proprioception | 1 | 2010 | 32 | 0.350 |
Why?
|
| Contraception | 1 | 2011 | 92 | 0.350 |
Why?
|
| Abortion, Induced | 2 | 2019 | 131 | 0.350 |
Why?
|
| Sexual Dysfunction, Physiological | 4 | 2018 | 69 | 0.340 |
Why?
|
| Urine | 3 | 2017 | 89 | 0.340 |
Why?
|
| Informed Consent | 2 | 2013 | 275 | 0.340 |
Why?
|
| Diagnostic Techniques, Urological | 5 | 2013 | 14 | 0.330 |
Why?
|
| Health Status Indicators | 5 | 2019 | 103 | 0.330 |
Why?
|
| Sleep Wake Disorders | 2 | 2022 | 117 | 0.330 |
Why?
|
| General Surgery | 2 | 2015 | 235 | 0.330 |
Why?
|
| Exercise Therapy | 4 | 2024 | 81 | 0.320 |
Why?
|
| Muscle Contraction | 5 | 2015 | 284 | 0.320 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 178 | 0.310 |
Why?
|
| Length of Stay | 4 | 2024 | 732 | 0.310 |
Why?
|
| Thermosensing | 1 | 2008 | 4 | 0.310 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 424 | 0.310 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2008 | 4 | 0.310 |
Why?
|
| Databases, Factual | 3 | 2020 | 850 | 0.310 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 988 | 0.310 |
Why?
|
| Botulinum Toxins | 1 | 2008 | 17 | 0.310 |
Why?
|
| Teaching | 2 | 2006 | 147 | 0.310 |
Why?
|
| Prosthesis Implantation | 3 | 2016 | 126 | 0.310 |
Why?
|
| Neurologic Examination | 1 | 2008 | 120 | 0.300 |
Why?
|
| Urinary Retention | 6 | 2024 | 42 | 0.300 |
Why?
|
| Prevalence | 11 | 2024 | 1240 | 0.290 |
Why?
|
| Pain Threshold | 2 | 2009 | 61 | 0.290 |
Why?
|
| Adolescent | 13 | 2023 | 9237 | 0.290 |
Why?
|
| Patient Selection | 4 | 2024 | 682 | 0.290 |
Why?
|
| Recovery of Function | 6 | 2021 | 292 | 0.280 |
Why?
|
| Urinary Tract Infections | 3 | 2019 | 76 | 0.280 |
Why?
|
| Narcotics | 2 | 2021 | 70 | 0.280 |
Why?
|
| Touch | 1 | 2008 | 95 | 0.280 |
Why?
|
| Obesity | 4 | 2024 | 966 | 0.280 |
Why?
|
| Aging | 3 | 2011 | 716 | 0.280 |
Why?
|
| Sensation | 3 | 2012 | 47 | 0.280 |
Why?
|
| Anatomy | 1 | 2006 | 20 | 0.280 |
Why?
|
| Research | 1 | 2007 | 252 | 0.270 |
Why?
|
| Combined Modality Therapy | 5 | 2021 | 1710 | 0.270 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2022 | 248 | 0.270 |
Why?
|
| Foreign-Body Migration | 2 | 2005 | 39 | 0.260 |
Why?
|
| Sexual Dysfunctions, Psychological | 3 | 2018 | 35 | 0.260 |
Why?
|
| Education | 2 | 2020 | 58 | 0.250 |
Why?
|
| Urology | 5 | 2020 | 117 | 0.250 |
Why?
|
| Sacrum | 5 | 2024 | 43 | 0.250 |
Why?
|
| Polypropylenes | 3 | 2023 | 23 | 0.250 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 385 | 0.240 |
Why?
|
| Linear Models | 5 | 2021 | 421 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1194 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 359 | 0.240 |
Why?
|
| Depression, Postpartum | 1 | 2024 | 14 | 0.230 |
Why?
|
| Electric Stimulation | 4 | 2021 | 354 | 0.230 |
Why?
|
| Sex Factors | 3 | 2023 | 1063 | 0.230 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 71 | 0.230 |
Why?
|
| Poland | 2 | 2020 | 18 | 0.230 |
Why?
|
| Depression | 4 | 2024 | 503 | 0.230 |
Why?
|
| Blood Loss, Surgical | 3 | 2024 | 115 | 0.230 |
Why?
|
| Vaginal Smears | 2 | 2014 | 70 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 531 | 0.220 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 466 | 0.220 |
Why?
|
| Implantable Neurostimulators | 2 | 2014 | 12 | 0.220 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 27 | 0.220 |
Why?
|
| White Matter | 1 | 2024 | 84 | 0.220 |
Why?
|
| Program Evaluation | 3 | 2011 | 306 | 0.220 |
Why?
|
| Pelvic Girdle Pain | 1 | 2022 | 1 | 0.220 |
Why?
|
| Electrodes | 3 | 2011 | 88 | 0.220 |
Why?
|
| Gardnerella | 1 | 2022 | 2 | 0.220 |
Why?
|
| Health Behavior | 2 | 2022 | 184 | 0.210 |
Why?
|
| Life Change Events | 1 | 2022 | 48 | 0.210 |
Why?
|
| Low Back Pain | 1 | 2022 | 41 | 0.210 |
Why?
|
| Abdominoplasty | 1 | 2022 | 2 | 0.200 |
Why?
|
| Women's Health | 3 | 2022 | 102 | 0.200 |
Why?
|
| Patient Discharge | 2 | 2022 | 320 | 0.200 |
Why?
|
| Linguistics | 1 | 2021 | 12 | 0.200 |
Why?
|
| Surgical Oncology | 2 | 2020 | 27 | 0.200 |
Why?
|
| Granulation Tissue | 1 | 2021 | 15 | 0.200 |
Why?
|
| Algorithms | 6 | 2019 | 1875 | 0.200 |
Why?
|
| Foreign Bodies | 1 | 2002 | 66 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 461 | 0.190 |
Why?
|
| Rectum | 1 | 2002 | 148 | 0.190 |
Why?
|
| Sutures | 4 | 2024 | 53 | 0.190 |
Why?
|
| Remission, Spontaneous | 1 | 2021 | 53 | 0.190 |
Why?
|
| Muscle, Striated | 1 | 2021 | 6 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2021 | 20 | 0.190 |
Why?
|
| Translations | 1 | 2020 | 5 | 0.190 |
Why?
|
| Urinary Bladder Fistula | 1 | 2020 | 4 | 0.190 |
Why?
|
| Tobacco Use | 1 | 2021 | 27 | 0.190 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 12 | 0.180 |
Why?
|
| Research Design | 3 | 2014 | 597 | 0.180 |
Why?
|
| Clinical Coding | 1 | 2020 | 24 | 0.180 |
Why?
|
| Age Factors | 5 | 2018 | 1867 | 0.180 |
Why?
|
| Estradiol | 1 | 2021 | 250 | 0.180 |
Why?
|
| Menorrhagia | 1 | 2021 | 26 | 0.180 |
Why?
|
| Tolterodine Tartrate | 5 | 2011 | 15 | 0.180 |
Why?
|
| Estrogens | 1 | 2021 | 201 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2024 | 351 | 0.180 |
Why?
|
| Body Mass Index | 5 | 2018 | 771 | 0.180 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1067 | 0.180 |
Why?
|
| Risk Assessment | 7 | 2021 | 2290 | 0.180 |
Why?
|
| Ureteral Obstruction | 1 | 2020 | 67 | 0.180 |
Why?
|
| Telemedicine | 1 | 2023 | 185 | 0.180 |
Why?
|
| Stress, Psychological | 3 | 2019 | 321 | 0.170 |
Why?
|
| Vibration | 3 | 2009 | 51 | 0.170 |
Why?
|
| Specialties, Surgical | 1 | 2020 | 65 | 0.170 |
Why?
|
| Documentation | 1 | 2020 | 103 | 0.170 |
Why?
|
| Decision Making | 2 | 2024 | 665 | 0.170 |
Why?
|
| Cough | 2 | 2012 | 55 | 0.170 |
Why?
|
| Hot Temperature | 3 | 2009 | 208 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 70 | 0.170 |
Why?
|
| Urinary Fistula | 1 | 2019 | 7 | 0.170 |
Why?
|
| Vaginal Fistula | 1 | 2019 | 5 | 0.170 |
Why?
|
| Circumcision, Female | 1 | 2019 | 4 | 0.170 |
Why?
|
| Ureteral Diseases | 1 | 2019 | 14 | 0.170 |
Why?
|
| Body Image | 2 | 2009 | 78 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 120 | 0.160 |
Why?
|
| Language | 1 | 2020 | 154 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 159 | 0.160 |
Why?
|
| Organization and Administration | 1 | 2018 | 10 | 0.160 |
Why?
|
| Wound Healing | 1 | 2021 | 359 | 0.160 |
Why?
|
| Perinatology | 1 | 2018 | 14 | 0.160 |
Why?
|
| Reproductive Medicine | 1 | 2018 | 9 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 410 | 0.160 |
Why?
|
| Activities of Daily Living | 2 | 2017 | 207 | 0.160 |
Why?
|
| Colposcopy | 3 | 2008 | 16 | 0.150 |
Why?
|
| Reference Values | 3 | 2008 | 661 | 0.150 |
Why?
|
| Genital Neoplasms, Female | 1 | 2019 | 108 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 205 | 0.150 |
Why?
|
| Focus Groups | 3 | 2023 | 170 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 63 | 0.150 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 22 | 0.150 |
Why?
|
| Self Report | 1 | 2019 | 295 | 0.150 |
Why?
|
| Phenotype | 1 | 2024 | 2439 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1043 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 167 | 0.150 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 201 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2018 | 125 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 257 | 0.150 |
Why?
|
| Rectal Diseases | 2 | 2007 | 24 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 106 | 0.140 |
Why?
|
| Microscopy | 1 | 2017 | 87 | 0.140 |
Why?
|
| Ultrasonography | 3 | 2022 | 711 | 0.140 |
Why?
|
| Medicare | 1 | 2020 | 423 | 0.140 |
Why?
|
| Weight-Bearing | 1 | 2017 | 67 | 0.140 |
Why?
|
| Physical Therapy Modalities | 2 | 2024 | 83 | 0.140 |
Why?
|
| Treatment Failure | 4 | 2011 | 287 | 0.140 |
Why?
|
| Coitus | 1 | 2016 | 20 | 0.140 |
Why?
|
| Disease Progression | 1 | 2021 | 1488 | 0.140 |
Why?
|
| Perineum | 3 | 2016 | 36 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 786 | 0.130 |
Why?
|
| Stents | 1 | 2019 | 395 | 0.130 |
Why?
|
| Predictive Value of Tests | 8 | 2013 | 1715 | 0.130 |
Why?
|
| Oocyte Retrieval | 1 | 2015 | 7 | 0.130 |
Why?
|
| Anxiety | 1 | 2018 | 308 | 0.130 |
Why?
|
| Cicatrix | 1 | 2016 | 68 | 0.130 |
Why?
|
| Psychometrics | 6 | 2013 | 329 | 0.130 |
Why?
|
| Qualitative Research | 3 | 2023 | 291 | 0.130 |
Why?
|
| Internet | 1 | 2018 | 318 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2023 | 192 | 0.130 |
Why?
|
| Urological Agents | 1 | 2015 | 5 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 981 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 32 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2016 | 118 | 0.120 |
Why?
|
| Ergonomics | 1 | 2014 | 22 | 0.120 |
Why?
|
| Health Surveys | 3 | 2010 | 240 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 257 | 0.120 |
Why?
|
| Illinois | 2 | 2018 | 472 | 0.120 |
Why?
|
| Perception | 3 | 2012 | 178 | 0.120 |
Why?
|
| Posture | 1 | 2014 | 124 | 0.120 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2014 | 3 | 0.120 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2014 | 2 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.120 |
Why?
|
| Vaginal Diseases | 1 | 2013 | 28 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2013 | 396 | 0.110 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2014 | 75 | 0.110 |
Why?
|
| Workload | 1 | 2014 | 129 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2015 | 354 | 0.110 |
Why?
|
| Incidence | 4 | 2021 | 1592 | 0.110 |
Why?
|
| Lactation | 1 | 2013 | 54 | 0.110 |
Why?
|
| Schools | 2 | 2024 | 75 | 0.110 |
Why?
|
| Motor Activity | 2 | 2012 | 327 | 0.110 |
Why?
|
| Lumbosacral Plexus | 1 | 2012 | 9 | 0.110 |
Why?
|
| Urinary Bladder Diseases | 2 | 2003 | 41 | 0.110 |
Why?
|
| Sexuality | 2 | 2010 | 41 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2014 | 156 | 0.110 |
Why?
|
| Habits | 2 | 2022 | 16 | 0.110 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 36 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 901 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2013 | 102 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2008 | 306 | 0.100 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2011 | 4 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 151 | 0.100 |
Why?
|
| Quinuclidines | 1 | 2011 | 26 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 2 | 2020 | 74 | 0.100 |
Why?
|
| Incidental Findings | 1 | 2012 | 98 | 0.100 |
Why?
|
| Cosmetic Techniques | 1 | 2011 | 28 | 0.100 |
Why?
|
| Action Potentials | 2 | 2012 | 596 | 0.100 |
Why?
|
| Health Status | 1 | 2013 | 370 | 0.090 |
Why?
|
| Urinalysis | 2 | 2012 | 31 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 261 | 0.090 |
Why?
|
| Motion | 1 | 2010 | 93 | 0.090 |
Why?
|
| Peer Group | 1 | 2011 | 81 | 0.090 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 372 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2011 | 160 | 0.090 |
Why?
|
| Recurrence | 2 | 2019 | 1140 | 0.090 |
Why?
|
| Libido | 1 | 2009 | 8 | 0.090 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 54 | 0.080 |
Why?
|
| Cystitis | 1 | 2009 | 14 | 0.080 |
Why?
|
| Obstetrical Forceps | 2 | 2021 | 9 | 0.080 |
Why?
|
| Skin | 2 | 2012 | 581 | 0.080 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2009 | 13 | 0.080 |
Why?
|
| Symptom Assessment | 2 | 2019 | 66 | 0.080 |
Why?
|
| Tissue Transplantation | 1 | 2008 | 12 | 0.080 |
Why?
|
| Hyperalgesia | 1 | 2009 | 20 | 0.080 |
Why?
|
| Hospitalization | 1 | 2015 | 876 | 0.080 |
Why?
|
| Overweight | 1 | 2009 | 119 | 0.080 |
Why?
|
| Emotions | 2 | 2023 | 349 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2008 | 160 | 0.080 |
Why?
|
| Pelvic Bones | 1 | 2008 | 43 | 0.080 |
Why?
|
| Muscle Hypertonia | 1 | 2008 | 17 | 0.080 |
Why?
|
| Organizational Objectives | 1 | 2008 | 24 | 0.080 |
Why?
|
| Office Visits | 2 | 2023 | 50 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1182 | 0.080 |
Why?
|
| Odds Ratio | 3 | 2020 | 684 | 0.080 |
Why?
|
| Perioperative Care | 1 | 2010 | 169 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 643 | 0.080 |
Why?
|
| Bacteria | 1 | 2012 | 472 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 155 | 0.070 |
Why?
|
| Urethral Diseases | 1 | 2007 | 15 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 370 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2008 | 232 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 149 | 0.070 |
Why?
|
| Canada | 1 | 2007 | 208 | 0.070 |
Why?
|
| Laparotomy | 1 | 2007 | 67 | 0.070 |
Why?
|
| Genital Diseases, Female | 1 | 2007 | 24 | 0.070 |
Why?
|
| Cost Control | 1 | 2006 | 45 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 28 | 0.070 |
Why?
|
| Anus Diseases | 1 | 2006 | 15 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 345 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 2001 | 0.070 |
Why?
|
| Reagent Strips | 1 | 2006 | 4 | 0.070 |
Why?
|
| Feedback, Psychological | 1 | 2006 | 19 | 0.070 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 153 | 0.070 |
Why?
|
| Colonic Diseases | 1 | 2006 | 61 | 0.070 |
Why?
|
| Competency-Based Education | 1 | 2006 | 36 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 2006 | 18 | 0.070 |
Why?
|
| Achievement | 1 | 2006 | 29 | 0.070 |
Why?
|
| Neuralgia | 1 | 2006 | 30 | 0.070 |
Why?
|
| Needles | 1 | 2006 | 36 | 0.070 |
Why?
|
| Equipment Design | 3 | 2012 | 415 | 0.070 |
Why?
|
| Students, Medical | 1 | 2011 | 418 | 0.060 |
Why?
|
| Bacteroides Infections | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cesarean Section, Repeat | 1 | 2005 | 3 | 0.060 |
Why?
|
| Catheterization | 1 | 2007 | 237 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1763 | 0.060 |
Why?
|
| Mentors | 1 | 2006 | 85 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 216 | 0.060 |
Why?
|
| Bacteroides fragilis | 1 | 2005 | 44 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2022 | 351 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 140 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2005 | 60 | 0.060 |
Why?
|
| Organ Size | 2 | 2021 | 369 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 124 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 105 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2005 | 126 | 0.060 |
Why?
|
| Nuclear Family | 1 | 2024 | 92 | 0.060 |
Why?
|
| Solifenacin Succinate | 2 | 2015 | 6 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 202 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2018 | 590 | 0.060 |
Why?
|
| Prescriptions | 1 | 2023 | 23 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 111 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2003 | 46 | 0.050 |
Why?
|
| Sacroiliac Joint | 1 | 2022 | 8 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 179 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2013 | 3443 | 0.050 |
Why?
|
| Tissue Adhesions | 1 | 2002 | 49 | 0.050 |
Why?
|
| Diarrhea | 2 | 2018 | 182 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 144 | 0.050 |
Why?
|
| Grooming | 1 | 2021 | 17 | 0.050 |
Why?
|
| Child | 2 | 2024 | 7149 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2021 | 96 | 0.050 |
Why?
|
| Intention to Treat Analysis | 2 | 2012 | 69 | 0.050 |
Why?
|
| Trial of Labor | 1 | 2021 | 5 | 0.050 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2021 | 6 | 0.050 |
Why?
|
| Maternal Age | 1 | 2021 | 45 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 32 | 0.050 |
Why?
|
| Polydioxanone | 1 | 2020 | 4 | 0.050 |
Why?
|
| Anesthesia, Epidural | 1 | 2021 | 32 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2020 | 48 | 0.050 |
Why?
|
| Fertility | 1 | 2021 | 116 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 833 | 0.050 |
Why?
|
| Organizational Innovation | 1 | 2020 | 41 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2021 | 147 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 212 | 0.040 |
Why?
|
| Dilatation and Curettage | 1 | 2019 | 3 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 457 | 0.040 |
Why?
|
| Pyelonephritis | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 636 | 0.040 |
Why?
|
| Conservative Treatment | 1 | 2019 | 21 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 146 | 0.040 |
Why?
|
| Catholicism | 1 | 2019 | 43 | 0.040 |
Why?
|
| Replantation | 1 | 2019 | 36 | 0.040 |
Why?
|
| Orgasm | 1 | 2018 | 9 | 0.040 |
Why?
|
| Ethiopia | 1 | 2018 | 37 | 0.040 |
Why?
|
| Age Distribution | 2 | 2009 | 200 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2018 | 51 | 0.040 |
Why?
|
| Physical Examination | 2 | 2009 | 148 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2008 | 70 | 0.040 |
Why?
|
| Mental Health | 1 | 2018 | 176 | 0.030 |
Why?
|
| Parity | 2 | 2009 | 96 | 0.030 |
Why?
|
| Esthetics | 1 | 2016 | 45 | 0.030 |
Why?
|
| Probability | 2 | 2009 | 353 | 0.030 |
Why?
|
| Pseudoephedrine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2015 | 11 | 0.030 |
Why?
|
| Imipramine | 1 | 2015 | 16 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 18 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 123 | 0.030 |
Why?
|
| Intention | 1 | 2015 | 51 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 36 | 0.030 |
Why?
|
| Animals | 4 | 2021 | 27317 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 778 | 0.030 |
Why?
|
| Intervertebral Disc | 1 | 2013 | 16 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2014 | 0.030 |
Why?
|
| Checklist | 1 | 2013 | 61 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 317 | 0.030 |
Why?
|
| Rest | 1 | 2012 | 49 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2012 | 78 | 0.030 |
Why?
|
| Bacteriuria | 1 | 2012 | 10 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2012 | 17 | 0.030 |
Why?
|
| Salpingectomy | 1 | 2011 | 3 | 0.020 |
Why?
|
| Chicago | 1 | 2016 | 1423 | 0.020 |
Why?
|
| Critical Care | 1 | 2015 | 380 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2011 | 81 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 160 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 104 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 150 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 242 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 192 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 449 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 740 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2012 | 278 | 0.020 |
Why?
|
| Femininity | 1 | 2009 | 3 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 53 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2009 | 36 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 50 | 0.020 |
Why?
|
| Prolapse | 1 | 2008 | 10 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 26 | 0.020 |
Why?
|
| Social Perception | 1 | 2009 | 95 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 866 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2008 | 51 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 948 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 166 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 234 | 0.020 |
Why?
|
| Drainage | 1 | 2009 | 162 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1097 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2009 | 296 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 52 | 0.020 |
Why?
|
| Polysomnography | 1 | 2008 | 151 | 0.020 |
Why?
|
| Cystocele | 1 | 2007 | 7 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 109 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2006 | 18 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2008 | 779 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 181 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 1149 | 0.020 |
Why?
|
| Hernia | 1 | 2003 | 23 | 0.010 |
Why?
|
| Labor Stage, First | 1 | 2003 | 3 | 0.010 |
Why?
|
| Science | 1 | 2004 | 34 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 207 | 0.010 |
Why?
|
| Labor Stage, Second | 1 | 2003 | 6 | 0.010 |
Why?
|
| Device Removal | 1 | 2005 | 167 | 0.010 |
Why?
|
| California | 1 | 2003 | 144 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2004 | 125 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 194 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2003 | 222 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 375 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 434 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3773 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2005 | 575 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 2362 | 0.010 |
Why?
|